16-fluoroestradiol has been researched along with Leiomyomatosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chino, Y; Okazawa, H; Tsujikawa, T; Tsuyoshi, H; Yoshida, Y | 1 |
1 other study(ies) available for 16-fluoroestradiol and Leiomyomatosis
| Article | Year |
|---|---|
A Novel Diagnostic Strategy Using 16α-[18F]-Fluoro-17-β-Estradiol (18F-FES) PET/MRI to Achieve Complete Resection of Intravenous Leiomyomatosis in Reproductive-Age Women.
Topics: Estradiol; Female; Humans; Leiomyomatosis; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Reproduction; Young Adult | 2017 |